Initially developed for obesity treatment, AOD9604 showed weight-reducing effects in rodent models comparable to those of full-length GH, but without inducing diabetes or stimulating IGF-1 production
A 12-week Phase IIa trial involving 300 participants showed modest reductions in weight (2.6 kg versus 0.8 kg for placebo)
Beyond skin and hair, the regenerative potential of GHK-Cu is explored in other contexts
Use sterile, single-use aliquots
Side effects: GLP-1 medications are frequently associated with nausea, constipation, gastroparesis, and, in some patients, significant muscle mass loss alongside fat loss
Chemical Information Chemical Name: 5-Amino-1-methylquinolinium Abbreviation: 5-Amino-1MQ CAS Number: 102365-69-1 Molecular Formula: C 10 H 10 N 2 Molecular Weight: 158.20 g/mol Form: Oral capsules, 50 mg Background & Research Findings what is 5-Amino-1MQ